Latest News
Rethinking Myasthenia Gravis: Release of the Policy Brief
The European Brain Council (EBC) is pleased to launch the Rethinking Myasthenia Gravis (MG) Policy Brief, a key outcome of the two-year Rethinking Myasthenia Gravis project. Launched during EBC’s Rare Disease Day event "Towards a Rare Brain Disease Ecosystem" in 2025, the project brings together researchers, clinicians, patient representatives, policymakers, and European Reference Networks to develop evidence-based recommendations aimed [...]
Registration launches for Brain Days at the 81st United Nations General Assembly
Registration is now open for the 5th edition of the Brain Days at the United Nations General Assembly, set to take place on 23rd and 24th of September in New York City. Taking place on the sidelines of the 81st United Nations General Assembly (UNGA81) during the High Level Week, the Brain Days 2026 will once again serve as [...]
Rethinking Schizophrenia in Germany: Schizophrenia and Brain Health
Building on the momentum of the Poland Country Profile and Denmark Country Profile, the Rethinking Schizophrenia initiative now turns its focus to Germany, examining how national policy can support more integrated, person-centred schizophrenia care. The Germany Country Profile builds on discussions from a Germany-focused webinar held on 4 March 2026, organised by the European Brain Council and the German [...]
EBC Welcomes S7 Joint Statement Calling for Brain Health to Become a Global Priority
The European Brain Council (EBC) warmly welcomes the publication of the S7 Academies Joint Statement “Advancing Brain Health (including Mental Health) for Global Societal Resilience”, delivered in the framework of the G7 process and calling for brain health to become a cross-cutting global policy priority. Signed by leading scientific academies from Canada, France, Germany, Italy, Japan, the United Kingdom [...]
Event Highlights: A European Strategy for Neurotechnology
Neurotechnology touches some of the most intimate dimensions of being human – cognition, behaviour, mental health, autonomy, identity. From brain implants restoring movement to consumer devices marketed for sleep and focus, it is reshaping healthcare and raising profound ethical questions at the same time. Europe is already the world’s second-largest neurotechnology market. But despite its scientific strength and strategic [...]
EBC Introduces the Seal of Responsible Neurotechnology
The European Brain Council is pleased to introduce the Seal of Responsible Neurotechnology, a voluntary ethical label to address unmet governance needs in the neurotechnology sector.Neurotechnology, encompassing devices and procedures that interact with the brain and nervous system, are increasingly deployed outside clinical settings, raising ethical questions about human agency, mental privacy and freedom of thought that existing EU regulations [...]
EBC at the 34th European Congress of Psychiatry in Prague
EBC at the 34th European Congress of Psychiatry The European Brain Council (EBC) was proud to participate in the 34th European Congress of Psychiatry, organised by the European Psychiatric Association (EPA) and held at the Prague Congress Centre from 28 to 31 March 2026. Gathering thousands of mental health professionals, researchers, policymakers and patient [...]
Event Highlights: Rethinking Schizophrenia in Germany – A Brain Health Approach to Schizophrenia Prevention and Care
Introduction Following the recommendations set out in the Rethinking Schizophrenia Care Pathway in Europe study paper, the next phase of the project — Country Profiles: Beyond Mental Health – A Brain Health Approach to Schizophrenia Prevention and Care — focuses on analysing country-specific models of care and identifying opportunities to improve prevention, early detection and integrated care across Europe. After a roundtable meeting in Poland in June [...]
Brain Health Day 2026: Building Momentum for a Coordinated European Vision for the Brain
On 18 March 2026, policymakers, researchers, clinicians, patient representatives and industry leaders gathered in Brussels for Brain Health Day: Prevention, Policy, Progress - a full day of activities organised by the Brain Health Mission, the European Academy of Neurology with the European Brain Council and the Federation of European Neuroscience Societies. Taking place during the 2026 Brain Awareness Week, [...]
EBC Questions the Relevance of NAMS as Part of the Biotech Act
The European Brain Council (EBC) welcomes the first part of the EU Biotech Act as proposed by the European Commission. It is indeed regarded as timely initiative to strengthen Europe’s capacity to translate its excellence in science into tangible health solutions. In particular, its aims to strengthen the EU’s biotechnology and biomanufacturing ecosystem, with an initial and explicit focus on health biotechnology, by reducing regulatory fragmentation, accelerating [...]